Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash

Ads

You May Also Like

Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership

MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine ...

Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco

DURHAM, N.C., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a ...